SPAC targets in the healthcare space typically are a few years away from full commercialization, but shareholders in Exelfin Acquisition Corp. (NASDAQ:XFIN) will get to vote this week on a combination with a medical device company that is already churning out positive EBITDA. ...READ MORE
Future Vision II Acquisition Corp. announced the pricing of its $50 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FVNNU”, Friday, September 12, 2024. ...READ MORE
Black Spade Acquisition II Co. (Nasdaq: BSIIU) announced the pricing of its $150 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “BSIIU” Wednesday, August 28. ...READ MORE
